SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $572,100 | -74.1% | 15,000 | -78.1% | 0.08% | -68.1% |
| Q2 2022 | $2,213,000 | +57.3% | 68,500 | +61.2% | 0.26% | +550.0% |
| Q1 2022 | $1,407,000 | -84.1% | 42,500 | -79.6% | 0.04% | -77.9% |
| Q4 2021 | $8,870,000 | +39.5% | 208,500 | +45.3% | 0.18% | -6.2% |
| Q3 2021 | $6,358,000 | -2.6% | 143,500 | +24.9% | 0.19% | -16.8% |
| Q2 2021 | $6,527,000 | -62.0% | 114,900 | -49.9% | 0.23% | -45.9% |
| Q1 2021 | $17,155,000 | +5877.4% | 229,200 | +7540.0% | 0.43% | +479.7% |
| Q4 2018 | $287,000 | – | 3,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |